Adults 14 to 17, any sex, with Depressive Symptoms or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Patient Health Questionnaire-8 AdolescentPrimary· 3 months and 6 months post baseline
The Patient Health Questionnaire-8 (PHQ-8) Adolescent has 8 items scored on a 4 point Likert scale summed for a total score ranging from 0-24. Higher scores indicate greater levels of depressive symptoms with a score of 10 indicating a moderate level of depressive symptoms. The population mean = 5.6 (SD = 1.0).
3 months post baseline
Group
Value
95% CI
Depression Management
6.17
± 1.33
Trust-building Self-management Together
9.43
± 6.32
6 months post baseline
Group
Value
95% CI
Depression Management
6.80
± 1.92
Trust-building Self-management Together
8.29
± 6.40
Youth Quality of Life ScaleSecondary· 3 and 6 months post baseline
The Youth Quality of Life Instrument-Short Form has 15 items measured on a 10 point Likert scale that are summed and t-scored, with higher scores indicating greater QoL. This is a continuously distributed scale without clinical cutoff scores. The quality of life mean t-score in the youth without depression (M= 81.0, SD= 11.7) is greater than the mean t-score in youth diagnosed with depression (M= 58.6, SD= 14.2).
3 months post baseline
Group
Value
95% CI
Depression Management
71.89
± 18.32
Trust-building Self-management Together
57.33
± 16.17
6 months post baseline
Group
Value
95% CI
Depression Management
64.93
± 17.10
Trust-building Self-management Together
61.71
± 13.47
Adolescent Sleep Hygiene ScaleSecondary· 3 and 6 months post baseline
The Adolescent Sleep Hygiene Scale-revised has 8 subscales with 24 items scored on a 6 point Likert scale. Each subscale total is the mean of the items contained within. The mean of the subscale scores indicates the overall sleep score, with higher scores indicating greater sleep hygiene. The range is 1-6, with poor sleep hygiene indicated by the lowest quintile scores, which is ≤ 3.8 and good sleep hygiene is indicated by the highest quintile score, which is ≥ 4.9.
3 months post baseline
Group
Value
95% CI
Depression Management
4.63
± 0.62
Trust-building Self-management Together
4.56
± 0.31
6 months post baseline
Group
Value
95% CI
Depression Management
4.73
± 0.47
Trust-building Self-management Together
4.17
± 0.34
Stress ManagementSecondary· 3 and 6 months post baseline
The Adolescent Lifestyle Questionnaire Stress Management Subscale has four items on a 5 point Likert scale that are summed for a total score. The range is 5-20. Higher scores indicate greater stress management behavior. This is a continuously distributed scale without clinical cutoff scores. The population mean = 13.0 (SD = 3.6).
3 months post baseline
Group
Value
95% CI
Depression Management
14.33
± 2.07
Trust-building Self-management Together
9.86
± 1.57
6 months post baseline
Group
Value
95% CI
Depression Management
13.40
± 2.41
Trust-building Self-management Together
12.43
± 2.15
Medication AdherenceSecondary· 3 and 6 months post baseline
The Extent of Non-Adherence Scale has 3 items measured on a 5-point Likert scale. A total score reflecting non-adherence is calculated by the mean of item responses, with a range of 1-5. Higher scores indicate greater levels of non-adherence and lower scores indicate greater adherence. The population mean = 1.8 (SD = 1.0).
3 months post baseline
Group
Value
95% CI
Depression Management
2.33
± 1.76
Trust-building Self-management Together
4.67
± 0.58
6 months post baseline
Group
Value
95% CI
Depression Management
2.08
± 1.26
Trust-building Self-management Together
4.00
± 1.41
Appointment KeepingSecondary· 3 and 6 months post baseline
The Hill-Bone Compliance Appointment Keeping Scale has 3 items measured on a four-point Likert scale. One item is reverse scored and then the three items are summed, resulting in a score ranging from 3-12. This is a continuously distributed scale without clinical cutoff scores. Lower scores indicate greater appointment keeping (M = 5.27 ± 0.93).
3 months post baseline
Group
Value
95% CI
Depression Management
7.40
± 1.95
Trust-building Self-management Together
8.67
± 1.53
6 months post baseline
Group
Value
95% CI
Depression Management
7.20
± 3.27
Trust-building Self-management Together
5.83
± 2.86
Sponsor's own description
This study evaluates the effectiveness of a novel depression self-management intervention in adolescents with depression.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07299903 — IMB-Based Sleep Hygiene Education for Menopausal Women: Effects on Sleep Quality and Depression
· NA
· recruiting
NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E
· NA
· recruiting
NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and
· NA
· recruiting
NCT07241325 — Psychological Well-Being, Depression, and Health-Related Quality of Life in Adults With Type 2 Diabetes: A Cross-Section
· recruiting
NCT07216326 — Our Voices Matter: Intervention for Depression in Youth
· NA
· recruiting
Other Case Western Reserve University trials
Trials by the same sponsor.
NCT07216950 — Knowledge and Interpersonal Skills to Develop Enhanced Relationships (KINDER)
· Phase 2
· not yet recruiting
NCT07006935 — REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
· NA
· not yet recruiting
NCT07214233 — Youth Empowerment and Safety Intervention
· NA
· recruiting
NCT07225582 — Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia
· NA
· recruiting
NCT07217249 — Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years
· NA
· enrolling by invitation
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Case Western Reserve University
Last refreshed: 9 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03599141.